Effects of Nefopam on Streptozotocin-Induced Diabetic Neuropathic Pain in Rats

BACKGROUND: Nefopam is a centrally acting non-opioid analgesic agent. Its analgesic properties may be related to the inhibitions of monoamine reuptake and the N-methyl-D-aspartate (NMDA) receptor. The antinociceptive effect of nefopam has been shown in animal models of acute and chronic pain and in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nam, Jae Sik, Cheong, Yu Seon, Karm, Myong Hwan, Ahn, Ho Soo, Sim, Ji Hoon, Kim, Jin Sun, Choi, Seong Soo, Leem, Jeong Gil
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Pain Society 2014
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196497/
https://ncbi.nlm.nih.gov/pubmed/25317281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3344/kjp.2014.27.4.326
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares